BVXV Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 sep 2023 @ 21:59):

Stats
Dagens volum	22 668.00
Gjennomsnittsvolum	38 939.00
Markedsverdi	4.97M
EPS	ILS0 ( 2023-11-29 )
Last Dividend	ILS0 ( N/A )
Next Dividend	ILS0 ( N/A )
P/E	-0.579
ATR14	ILS0.0550 (6.88%)

Insider Trading

Date	Person	Action	Amount	type
2023-01-01	Margolin Yael	Sell	133 200	Restricted Share Units
2023-01-01	Margolin Yael	Sell	0	Ordinary Shares
2023-01-01	Laster Morris C	Sell	133 200	Restricted Share Units
2023-01-01	Laster Morris C	Sell	0	Ordinary Shares
2023-01-01	Lowell George	Sell	133 200	Restricted Share Units

INSIDER POWER
-100.00
Last 23 transactions
Buy: 0 \| Sell: 12 745 600

Volum Korrelasjon

Lang: 0.06 (neutral)

Kort: -0.15 (neutral)

Signal:(16.452) Neutral

BiondVax Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
ODT	0.975
OPTN	0.97
TCDA	0.969
TTCF	0.966
STSA	0.962
FNWD	0.951
SNCE	0.95
PLXP	0.943
HIBB	0.938
AGRI	0.936

10 Mest negative korrelasjoner
BIOS	-0.955
CCRC	-0.955
SVFA	-0.95
OXUS	-0.943
SLAM	-0.942
SVFAU	-0.942
TZPSU	-0.941
ALPA	-0.94
COCO	-0.94
SCOB	-0.94

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

BiondVax Pharmaceuticals Korrelasjon - Valuta/Råvare

-0.66
( moderate negative )

-0.85
( strong negative )

0.66
( moderate )

-0.78
( moderate negative )

0.54
( weak )

BiondVax Pharmaceuticals Økonomi

Annual	2022
Omsetning:	ILS0
Bruttogevinst:	ILS0 (0.00 %)
EPS:	ILS0

FY	2022
Omsetning:	ILS0
Bruttogevinst:	ILS0 (0.00 %)
EPS:	ILS0

FY	2021
Omsetning:	ILS0.00
Bruttogevinst:	ILS0.00 (0.00 %)
EPS:	ILS-3.72

FY	2020
Omsetning:	ILS0.00
Bruttogevinst:	ILS0.00 (0.00 %)
EPS:	ILS-4.02

Financial Reports:

No articles found.

BiondVax Pharmaceuticals

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.